Bioequivalence of Complex Topical Generics: In Vitro and In Vivo
This presentation summarizes a series of FDA-coordinated, GDUFA-funded research studies included in a strategic multi-year, multi-million dollar research program to develop new, more efficient approaches by which to evaluate bioequivalence (BE) for topical generics.
This presentation summarizes a series of FDA-coordinated, GDUFA-funded research studies included in a strategic multi-year, multi-million dollar research program to develop new, more efficient approaches by which to evaluate bioequivalence (BE) for topical generics.
October 8, 2020; 12:00 PM - 1:00 PM ET
Please register here.
.png)
No hay comentarios:
Publicar un comentario